Nuwellis, Inc. (NASDAQ:NUWE) Short Interest Down 52.7% in February

Nuwellis, Inc. (NASDAQ:NUWE) was the target of a large decrease in short interest in February. As of February 15th, there was short interest totalling 264,200 shares, a decrease of 52.7% from the January 31st total of 558,100 shares. Based on an average trading volume of 561,500 shares, the short-interest ratio is presently 0.5 days. Approximately 6.1% of the shares of the company are short sold.

Nuwellis Stock Performance

Shares of Nuwellis stock traded down $0.05 during trading hours on Monday, reaching $1.20. The company’s stock had a trading volume of 93,505 shares, compared to its average volume of 996,511. Nuwellis has a one year low of $0.92 and a one year high of $22.05. The company’s 50 day simple moving average is $1.20 and its 200 day simple moving average is $1.36. The stock has a market cap of $5.25 million, a P/E ratio of -0.01 and a beta of 0.31.

Hedge Funds Weigh In On Nuwellis

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC purchased a new position in shares of Nuwellis, Inc. (NASDAQ:NUWE) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned about 0.70% of Nuwellis as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 3.13% of the company’s stock.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.